YMAB

Y-MABS THERAPEUTICS INC

Healthcare | Small Cap

-$0.13

EPS Forecast

$26.35

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Market expectations

EPS Expectation:

-$0.13

Revenue Expectation:

$26.35

EPS Surprise Expectation:

-$0.004

Revenue Surprise Expectation:

-$1

Post-release price volatility - Very high

Post-release Overnight Move:

±11.4%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: